News & Updates

Show Multimedia Only
Quercetin augments therapeutic benefit of antivirals for COVID-19

Quercetin augments therapeutic benefit of antivirals for COVID-19

03 Feb 2022 byAudrey Abella

In patients hospitalized for severe COVID-19, adding the plant flavonoid quercetin to the antiviral drugs remdesivir or favipiravir reduced hospitalization period and levels of inflammatory markers related to the pathogenesis of SARS-CoV-2, thus preventing the progression of the disease into its critical phase, suggests an open-label study from Iran.

03 Feb 2022
Reaction patterns may aid in diagnosis of COVID-19 vaccine-related cutaneous side effects

Reaction patterns may aid in diagnosis of COVID-19 vaccine-related cutaneous side effects

02 Feb 2022 byStephen Padilla

A registry-based study has recently shown diverse COVID-19 vaccine-associated dermatologic reactions, including papulovesicular, pityriasis rosea-like, and papulosquamous eruptions classified as vaccine-related eruption of papules and plaques (V-REPP).

02 Feb 2022
Certain groups of minority women more susceptible to vaginal infections

Certain groups of minority women more susceptible to vaginal infections

29 Jan 2022

A recent study has reported that women from non-Western countries are at increased risk of genital infections. Younger age also contributes to a risk increase, while living outside of larger cities seems to have a protective effect.

29 Jan 2022